EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

VHH Nanobody Versatility against Pentameric Ligand-Gated Ion Channels

Dorota Nemecz, Weronika A Nowak, Ákos Nemecz iD

Journal of Medicinal Chemistry · 13.06.2024 · 67 (11) · 8502-8518

DOI: 10.1021/acs.jmedchem.4c00231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.06.2024. Verfasst von Dorota Nemecz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland. Hauptthemen laut MEDLINE: Single-Domain Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norway Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pentameric ligand-gated ion channels provide rapid chemical-electrical signal transmission between cells in the central and peripheral nervous system. Their dysfunction is associated with many nervous system disorders. They are composed of five identical (homomeric receptors) or homologous (heteromeric receptors) subunits. VHH nanobodies, or single-chain antibodies, are the variable domain, VHH, of antibodies that are composed of the heavy chain only from camelids. Their unique structure results in many specific biochemical and biophysical properties that make them an excellent alternative to conventional antibodies. This Perspective explores the published VHH nanobodies which have been isolated against pentameric ligand-gated ion channel subfamilies. It outlines the genetic and chemical modifications available to alter nanobody function. An assessment of the available functional and structural data indicate that it is feasible to create therapeutic agents and impart, through their modification, a given desired modulatory effect of its target receptor for current stoichiometric-specific VHH nanobodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesHumansAnimalsLigand-Gated Ion ChannelsModels, Molecular

Substanzen

Single-Domain AntibodiesLigand-Gated Ion Channels

Autor:innen und Institutionen

  • Biochemistry Department, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.

ORCID-Profile: Ákos Nemecz

Förderung

  • Norway Grants

Zitieren

APA

Nemecz, D., Nowak, W. A., & Nemecz, Á. (2024). VHH Nanobody Versatility against Pentameric Ligand-Gated Ion Channels. Journal of Medicinal Chemistry, 67(11), 8502-8518. https://doi.org/10.1021/acs.jmedchem.4c00231

Vancouver

Nemecz D, Nowak WA, Nemecz Á. VHH Nanobody Versatility against Pentameric Ligand-Gated Ion Channels. Journal of Medicinal Chemistry. 2024;67(11):8502-8518. doi:10.1021/acs.jmedchem.4c00231

BibTeX
@article{Nemecz2024,
  author = {Nemecz, Dorota and Nowak, Weronika A and Nemecz, Ákos},
  title = {VHH Nanobody Versatility against Pentameric Ligand-Gated Ion Channels},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {11},
  pages = {8502--8518},
  doi = {10.1021/acs.jmedchem.4c00231}
}
Kostenlos starten →